GNPX · NASDAQ
Genprex (GNPX) Stock Price & Fundamentals
Genprex (GNPX) closed at $613.51 on Oct 9, 2026, up 1.81% from the previous close of $602.60.
Share price, past year
1Y −20.07%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $613.51 |
| Sep 30, 2026 | $589.51 |
| Aug 31, 2026 | $623.72 |
| Jul 31, 2026 | $616.20 |
| Jun 30, 2026 | $674.48 |
| May 29, 2026 | $709.88 |
| Apr 30, 2026 | $724.28 |
| Mar 31, 2026 | $732.12 |
| Feb 27, 2026 | $729.67 |
| Jan 30, 2026 | $741.29 |
| Dec 31, 2025 | $740.00 |
| Nov 28, 2025 | $797.01 |
| Oct 31, 2025 | $761.34 |
Key statistics
- Market cap
- $310.57M
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- −$16.50M
- Shares outstanding
- 506.2K
- Dividend yield
- —
- 52-week range
- $585.35 – $797.01
Genprex's market cap is $310.57M, based on a share price of $613.51 and 506.2K shares outstanding as of Jun 30, 2026.
Financials
Genprex reported revenue of $0.00 for fiscal 2024.
Genprex reported a net loss of $16.23M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2024ended Dec 31, 2024 | $0.00 | — | −$21.11M | — | — | — |
| FY2023ended Dec 31, 2023 | $0.00 | — | −$30.86M | — | — | — |
| FY2022ended Dec 31, 2022 | $0.00 | — | −$23.74M | — | — | −$17.62M |
| FY2021ended Dec 31, 2021 | $0.00 | — | −$20.66M | — | −$0.42 | −$14.32M |
| FY2020ended Dec 31, 2020 | $0.00 | — | −$17.94M | — | −$0.51 | −$13.95M |
| FY2018ended Dec 31, 2018 | $0.00 | — | −$12.37M | — | −$0.90 | −$6.87M |
| FY2017ended Dec 31, 2017 | $0.00 | — | −$3.31M | — | −$0.29 | −$2.18M |
| FY2016ended Dec 31, 2016 | $0.00 | — | −$4.13M | — | −$0.38 | −$1.25M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q4 FY2022ended Dec 31, 2022 | $0.00 | — | — |
| Q3 FY2022ended Sep 30, 2022 | $0.00 | — | — |
| Q2 FY2022ended Jun 30, 2022 | $0.00 | — | — |
| Q1 FY2022ended Mar 31, 2022 | $0.00 | — | — |
| Q4 FY2021ended Dec 31, 2021 | $0.00 | — | −$0.13 |
| Q3 FY2021ended Sep 30, 2021 | $0.00 | — | −$0.07 |
| Q2 FY2021ended Jun 30, 2021 | $0.00 | — | −$0.08 |
| Q1 FY2021ended Mar 31, 2021 | $0.00 | — | −$0.14 |
Company profile
- Name
- Genprex, Inc.
- Ticker
- GNPX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 3300 Bee Cave Road Suite 650-227, Austin, TX 78746
- Incorporated in
- TX
- Fiscal year ends
- December
- SEC CIK
- 0001595248
Recent SEC filings
- Aug 18, 2026
- Aug 14, 2026
- Aug 5, 2026
- Aug 3, 2026
- Jul 30, 2026
- Jul 14, 2026
- Jun 22, 2026
- Jun 18, 2026
Frequently asked questions
What is Genprex's stock price?
Genprex (GNPX) closed at $613.51 on Oct 9, 2026, up 1.81% from the previous close of $602.60.
What is Genprex's market cap?
Genprex's market cap is $310.57M, based on a share price of $613.51 and 506.2K shares outstanding as of Jun 30, 2026.
How much revenue does Genprex make?
Genprex reported revenue of $0.00 for fiscal 2024.
Does Genprex pay a dividend?
Genprex's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Genprex, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures